What Causes Male Pattern Baldness?
Androgenetic alopecia is driven by dihydrotestosterone (DHT), a hormone derived from testosterone via the enzyme 5-alpha reductase. In genetically susceptible men, DHT binds to receptors in scalp hair follicles, causing them to miniaturize — producing progressively thinner, shorter hairs until they stop growing entirely.
The Norwood Scale
Hair loss severity is measured on the Norwood scale (I-VII). Type I shows no significant hair loss. Type II-III shows recession at the temples. Type IV-V shows significant thinning at the crown. Type VI-VII represents advanced baldness. Treatment is most effective at stages II-IV.
FDA-Approved Treatments
Finasteride (oral, 1mg daily) blocks DHT production by ~70%. Minoxidil (topical, 5%) stimulates blood flow to follicles and extends the growth phase. Used together, they produce superior results — 94% improvement at 12 months versus 80% (finasteride alone) or 59% (minoxidil alone).
Emerging Options
Topical finasteride offers lower systemic absorption with comparable scalp DHT reduction. Low-level laser therapy (LLLT) shows modest benefit as an adjunct treatment. Platelet-rich plasma (PRP) injections have promising but inconsistent evidence.
Getting Started with Clyne
A Clyne provider evaluates your hair loss pattern, reviews your health history, and recommends a personalized treatment plan — all through a same-day online consultation. Treatment ships directly to your door.
Ready to take the next step?
Get started with a personalized treatment plan reviewed by a licensed physician.
Start your free visit with a licensed physicianEditorial standards
This content is reviewed by Clyne®'s editorial team and grounded in published clinical evidence. Citations are listed at the end of each piece. Clyne® Concierge translates the science; your physician makes all clinical decisions. We never fabricate trial data, patient stories, or outcomes.
Last reviewed:
